Clinical Trial Update: Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of eszopiclone in patients with generalized anxiety disorder, including those with comorbid insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia, Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED